Skip to main content
logo
Gufic Biosciences Limited (NSE:GUFICBIO)
India flag India · Delayed Price · Currency is INR
288.60
-0.10 (-0.03%)
Apr 2, 2026, 3:29 PM IST

Gufic Biosciences Revenue

Gufic Biosciences had revenue of 2.31B INR in the quarter ending December 31, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to 8.97B, up 10.80% year-over-year. In the fiscal year ending March 31, 2025, Gufic Biosciences had annual revenue of 8.20B with 1.63% growth.

Revenue (ttm)
8.97B
Revenue Growth
+10.80%
P/S Ratio
3.24
Revenue / Employee
6.05M
Employees
1,484
Market Cap
29.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20258.20B131.40M1.63%
Mar 31, 20248.07B1.16B16.80%
Mar 31, 20236.91B-885.35M-11.36%
Mar 31, 20227.79B2.91B59.76%
Mar 31, 20214.88B1.09B28.74%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aarti Pharmalabs18.01B
Indoco Remedies17.60B
Innova Captab14.97B
Solara Active Pharma Sciences12.55B
Windlas Biotech8.68B
Orchid Pharma8.11B
RPG Life Sciences6.74B
Sudeep Pharma6.17B
Revenue Rankings

Gufic Biosciences News

More News